JDHIF (JD Health International) Stock Based Compensation: $0 Mil (TTM As of Dec. 2025)


JDHIF JD Health International Inc JDHIF
90 GF Score
Price $5.85
GF Value $10.42
! 1 Warning Sign
View Full Analysis

What is JD Health International Stock Based Compensation?

JD Health International JDHIF 90 Stock Based Compensation is $0 Mil as of Dec. 2025. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review.

JD Health International's Stock Based Compensation for the six months ended in Dec. 2025 was $0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

JD Health International Stock Based Compensation Related Terms

JD Health International Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for JD Health International's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International Stock Based Compensation Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 405.02 301.83 258.79 155.15 83.87

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JDHIF
90GF Score
JD Health International Inc JDHIF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

What does a Stock Based Compensation of $0 Mil mean?
JD Health International (JDHIF) has a Stock Based Compensation of $0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for JD Health International and its competitors.
Is JD Health International's Stock Based Compensation too high?
JD Health International's current Stock Based Compensation is $0 Mil. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Stock Based Compensation compare to competitors?
JD Health International's Stock Based Compensation of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for JD Health International and its competitors. JD Health International's current Stock Based Compensation is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current Stock Based Compensation of $0 Mil. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current Stock Based Compensation is $0 Mil. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For JD Health International (JDHIF), the current Stock Based Compensation is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JD Health International (JDHIF) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.

Key valuation signals for JDHIF:

  • Stock Based Compensation: $0 Mil
  • GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score

Get the complete analysis for JDHIF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.85
Price
$10.42
GF Value